<DOC>
	<DOCNO>NCT00969787</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics pharmacodynamics orally administrate DWP05195 healthy male volunteer .</brief_summary>
	<brief_title>DWP05195 Healthy Adult Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy adult male subject age 20 45 year The subject Body weight ≥ 50 kg &lt; 90 kg Body Mass Index ( BMI ) ≥ 19.0 kg/m2 &lt; 27.0 kg/m2 A subject provide write informed consent participate study cooperative regard compliance study relate constraint A Subject judge healthy investigator participate study base screen result ( accord standard reference index update recently ) A subject sign symptom previously diagnose disease respiratory , cardiovascular , endocrinology , liver , kidney , gastrointestinal , hematology , neurology psychology function significant diseases history suspicion current drug abuse alcohol abuse A subject allergic history drug ( prescription drug OTC medication etc . ) A subject receive treatment list drug within specified period prior first dose study medication Within last 1 month : drug food know CYP1A2 inducer inhibitor Within 2 week : Prescribed herbal Nonprescribed medicine Within 3 day : Consumption grapefruit juice/grapefruit contain product orange juice/orange containing product , garlic extract functional food Within 3 day : Consumption alcohol caffeine A subject participate clinical study within last 12 week A subject 400mL blood sample ( whole blood plasma donation , etc . ) within last 12 week A Subject know evidence follow infection drug abuse HIV , HBs , HCV cannabinoid , opioid , amphetamine , cocaine , barbiturate , benzodiazepine Smoker smoking cessation within 1 month exsmoker positive result cotinine test AST ALT great 1.5 time upper limit reference range QTc &gt; 430 msec base screen result Blood pressure : SBP ≥ 140 mmHg , DBP ≤ 85 mmHg A subject judge ineligible investigator participate study reason contain clinical laboratory test</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>